NewAmsterdam Pharma Company N.V. (NAMS) PE Ratio

NewAmsterdam Pharma Company N.V. (NAMS) PE ratio history, current valuation, and earnings analysis. Track price-to-earnings trends in Excel with MarketXLS.

PE Ratio Data

PeriodPE Ratio
2022-12-31-35.50
2023-12-31-15.85
2024-12-31-13.31

Get NewAmsterdam Pharma Company N.V. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =PERatio("NAMS")

BUY NOW